Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy

On: April 19, 2026, 12:27 pm EDT

URL has been copied successfully!

Share this story:

Previous Post:Telix Pharmaceuticals (TLX) Doses First Patient in Phase 3 Trial for Brain Cancer Therapy

Next Post:Calumet (CLMT) Closes $150M Private Placement of Senior Notes